Investigating the causes and effects of primary aldosteronism subtypes
Primary Aldosteronism Subtypes: Pathophysiology and Steroid Signatures
This study is looking at primary aldosteronism, a condition that causes high blood pressure, to find better ways to diagnose it using blood tests and tissue samples, so patients can get the right treatment without needing invasive procedures.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11031933 on NIH RePORTER |
What this research studies
This research focuses on primary aldosteronism (PA), a common adrenal disorder that leads to high blood pressure and serious cardiovascular issues. The study aims to better understand the different types of PA by analyzing tissue samples and blood tests to identify specific steroid signatures. By improving diagnostic methods, the research seeks to reduce the need for invasive procedures currently used to subtype PA, making it easier for patients to receive accurate diagnoses and appropriate treatments. Ultimately, this work could lead to more effective management of PA and its associated health risks.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with primary aldosteronism, particularly those who may benefit from improved diagnostic techniques.
Not a fit: Patients with primary aldosteronism who have already undergone successful treatment or those with other unrelated adrenal disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide patients with a less invasive and more accurate way to diagnose and manage primary aldosteronism.
How similar studies have performed: Previous research has shown promise in improving diagnostic methods for adrenal disorders, suggesting that this approach may lead to significant advancements in the field.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Turcu, Adina F — University of Michigan at Ann Arbor
- Study coordinator: Turcu, Adina F
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.